Clinical Study on the Use of Huaier Granules for the Treatment of Proteinuria Related to Bevacizumab and Anlotinib in Lung Cancer Patients
NCT07358520
·
clinicaltrials.gov ↗
PHASE4
Phase
NOT_YET_RECRUITING
Status
40
Enrollment
OTHER
Sponsor class
Conditions
Proteinuria
Interventions
DRUG:
Huaier Granule
DRUG:
Anlotinib and Bevacizumab
Sponsor
Fudan University